Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.30 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
| ▸ | CES2 | O00748 | 1/20 | 0.30 |
| ▸ | CES1 | P23141 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2694587 | 1.00 | DNM1 (0.31) | DNM1MEN1TP53MAPK1KMT2A | |
| SCHEMBL29593791 | 1.00 | DNM1 (0.31) | DNM1MEN1TP53MAPK1KMT2A | |
| SCHEMBL30767131 | 1.00 | DNM1 (0.31) | DNM1MEN1TP53MAPK1KMT2A | |
| SCHEMBL16715263 | 1.00 | DNM1 (0.31) | DNM1MEN1TP53MAPK1KMT2A | |
| SCHEMBL16715253 | 1.00 | DNM1 (0.31) | DNM1MEN1TP53MAPK1KMT2A | |
| SCHEMBL23647856 | 1.00 | DNM1 (0.31) | DNM1MEN1TP53MAPK1KMT2A | |
| SCHEMBL29970321 | 1.00 | DNM1 (0.31) | DNM1MEN1TP53MAPK1KMT2A | |
| SCHEMBL22283328 | 1.00 | DNM1 (0.31) | DNM1MEN1TP53MAPK1KMT2A | |
| SCHEMBL22283325 | 1.00 | DNM1 (0.31) | DNM1MEN1TP53MAPK1KMT2A | |
| SCHEMBL8965996 | 0.94 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3689884-B1 | NOVEL INDENE-BASED TRANSITION METAL COMPOUND, TRANSITION METAL CATALYST COMPOSITION COMPRISING SAME, AND METHOD FOR PREPARING ETHYLENE HOMOPOLYMER OR COPOLYMER OF ETHYLENE AND ALPHA-OLEFIN BY USING SAME | SABIC SK NEXLENE COMPANY PTE LTD (SG) | 2024-07-10 | — | — | EP | claimed |
| US-10919992-B2 | Indene-based transition metal compound, transition metal catalyst composition comprising same, and method for preparing ethylene homopolymer or copolymer of ethylene and alpha-olefin by using same | SABIC SK NEXLENE COMPANY PTE. LTD. (SG) | 2021-02-16 | — | — | US | claimed |
| US-20200262943-A1 | NOVEL INDENE-BASED TRANSITION METAL COMPOUND, TRANSITION METAL CATALYST COMPOSITION COMPRISING SAME, AND METHOD FOR PREPARING ETHYLENE HOMOPOLYMER OR COPOLYMER OF ETHYLENE AND ALPHA-OLEFIN BY USING SAME | SABIC SK NEXLENE COMPANY PTE. LTD. (SG) | 2020-08-20 | — | — | US | claimed |
| EP-3689884-A1 | NOVEL INDENE-BASED TRANSITION METAL COMPOUND, TRANSITION METAL CATALYST COMPOSITION COMPRISING SAME, AND METHOD FOR PREPARING ETHYLENE HOMOPOLYMER OR COPOLYMER OF ETHYLENE AND -OLEFIN BY USING SAME | Sabic Sk Nexlene Company Pte. Ltd. (SG) | 2020-08-05 | — | — | EP | claimed |
| EP-4509515-B1 | LIGAND COMPOUND, ORGANIC CHROMIUM COMPOUND, AND CATALYST COMPOSITION COMPRISING SAME | LG CHEMICAL LTD (KR) | 2026-04-29 | — | — | EP | disclosed |
| US-12577328-B2 | Borate compound-containing composition | AGC Inc. (JP) | 2026-03-17 | — | — | US | disclosed |
| US-12577264-B2 | Borate compound-containing composition | AGC Inc. (JP) | 2026-03-17 | — | — | US | disclosed |
| EP-4700033-A1 | LIGAND COMPOUND, ORGANIC CHROMIUM COMPOUND AND CATALYST COMPOSITION COMPRISING SAME | LG Chem, Ltd. (KR) | 2026-02-25 | — | — | EP | disclosed |
| EP-4700031-A1 | LIGAND COMPOUND, ORGANIC CHROMIUM COMPOUND, AND CATALYST COMPOSITION COMPRISING SAME | LG Chem, Ltd. (KR) | 2026-02-25 | — | — | EP | disclosed |
| EP-4119533-B1 | NOVEL BORATE COMPOUND-CONTAINING COMPOSITION | AGC INC (JP) | 2026-02-18 | — | — | EP | disclosed |
| US-20250381558-A1 | Ligand Compound, Organic Chromium Compound, and Catalyst Compositions Containing the Same | LG CHEM, LTD. (KR) | 2025-12-18 | — | — | US | disclosed |
| EP-4559921-B1 | LIGAND COMPOUND, ORGANIC CHROMIUM COMPOUND AND CATALYST COMPOSITION COMPRISING SAME | LG CHEMICAL LTD (KR) | 2025-11-26 | — | — | EP | disclosed |
| US-20030204017-A1 | Isotactic propylene copolymers, their preparation and use | DOW GLOBAL TECHNOLOGIES LLC | 2003-10-30 | — | — | US | disclosed |
| WO-2003040201-A1 | ISOTACTIC PROPYLENE COPOLYMERS, THEIR PREPARATION AND USE | DOW GLOBAL TECHNOLOGIES INC. (US) | 2003-05-15 | — | — | WO | disclosed |
| US-20030088037-A1 | Method of making interpolymers and products made therefrom | THE DOW CHEMICAL COMPANY (US) | 2003-05-08 | — | — | US | disclosed |
| US-20020183464-A1 | 3-aryl-substituted cyclopentadienyl metal complexes and polymerization process | DOW GLOBAL TECHNOLOGIES LLC | 2002-12-05 | — | — | US | disclosed |
| US-20020151662-A1 | Substituted polycyclic, fused ring compounds, metal complexes and polymerization process | DOW GLOBAL TECHNOLOGIES LLC | 2002-10-17 | — | — | US | disclosed |
| WO-2002074817-A2 | METHOD OF MAKING INTERPOLYMERS AND PRODUCTS MADE THEREFROM | DOW GLOBAL TECHNOLOGIES INC. (US) | 2002-09-26 | — | — | WO | disclosed |
| US-20020082161-A1 | Diene functionalized catalyst supports and supported catalyst compositions | THE DOW CHEMICAL COMPANY | 2002-06-27 | — | — | US | disclosed |
| WO-2001058912-A1 | DINUCLEAR GROUP 4 METAL BORON OR ALUMINUM BRIDGE CONTAINING ANSA-COMPLEXES | THE DOW CHEMICAL COMPANY (US) | 2001-08-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020183464-A1 | 3-aryl-substituted cyclopentadienyl metal complexes and polymerization process | SOD1, AOC3, PPOX | DNM1 1233/4885MEN1 4838/4885TP53 3299/4885 |
| US-12577264-B2 | Borate compound-containing composition | AFF1, RFC1, RFC3 | DNM1 4011/4885MEN1 560/4885TP53 4641/4885 |
| US-12577328-B2 | Borate compound-containing composition | AHR, MLLT3, RER1 | DNM1 4211/4885MEN1 1423/4885TP53 2948/4885 |
| US-20250381558-A1 | Ligand Compound, Organic Chromium Compound, and Catalyst Compositions Containing the Same | EXOC1, OXER1, ORC3 | DNM1 2962/4885MEN1 1400/4885TP53 1786/4885 |
| US-10919992-B2 | Indene-based transition metal compound, transition metal catalyst composition comprising same, and method for preparing ethylene homopolymer or copolymer of ethylene and alpha-olefin by using same | ETFB, EMC2, ICMT | DNM1 188/4885MEN1 392/4885TP53 2928/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.